ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ANIK Anika Therapeutics Inc

26.49
0.00 (0.00%)
Pre Mercado
Última actualización: 07:00:45
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Anika Therapeutics Inc ANIK NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 26.49 07:00:45
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
26.49
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/4/202415:01GLOBEAnika to Issue First Quarter 2024 Financial Results on..
02/4/202407:00GLOBEAnika to Participate in the 23rd Annual Needham Virtual..
13/3/202415:05GLOBEAnika Reports Fourth Quarter and Year-End 2023 Financial..
13/3/202406:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
08/3/202415:01GLOBEAnika Reports Inducement Grants Under Nasdaq Listing Rule..
06/3/202418:30EDGAR2Form SC 13D/A - General statement of acquisition of..
27/2/202415:01GLOBEAnika to Issue Fourth Quarter and Year-End 2023 Financial..
26/2/202408:00EDGAR2Form 8-K - Current report
13/2/202408:00GLOBEAnika Highlights Its Recently Launched Integrity™ Implant..
09/2/202410:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202413:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202408:29EDGAR2Form S-8 POS - Securities to be offered to employees in..
19/1/202415:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/1/202415:35EDGAR2Form 3/A - Initial statement of beneficial ownership of..
28/11/202308:00GLOBEAnika Announces First Surgeries Performed using the..
07/11/202315:05GLOBEAnika to Participate in Upcoming Investor Conferences
02/11/202315:11EDGAR2Form 8-K - Current report
02/11/202315:05GLOBEAnika Reports Third Quarter 2023 Financial Results and..
10/10/202308:00GLOBEAnika to Issue Third Quarter 2023 Financial Results on..
03/10/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202306:55EDGAR2Form 8-K - Current report
19/9/202308:00GLOBEAnika Announces the Full Market Release of the RevoMotion™..
15/9/202315:01GLOBEAnika Reports Inducement Grants Under Nasdaq Listing Rule..
12/9/202308:00GLOBEAnika to Participate in the Sidoti Small Cap Virtual..
11/9/202305:01EDGAR2Form SC 13D/A - General statement of acquisition of..
01/9/202317:51PRNUSBlackstone and Airbnb Set to Join S&P 500; Others to Join..
17/8/202318:57DJNAnika Rotator-Cuff Treatment May Launch in 1Q Following..
17/8/202317:20GLOBEAnika Receives 510(k) Clearance for Integrity™ Implant..
17/8/202307:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/8/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202316:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:11EDGAR2Form 8-K - Current report
08/8/202315:05GLOBEAnika Reports Second Quarter 2023 Financial Results
20/7/202315:05GLOBEAnika to Issue Second Quarter 2023 Financial Results on..
12/7/202308:00GLOBEAnika Showcases Highly Differentiated Joint Preservation and..
30/5/202315:05GLOBEAnika Completes Enrollment in Hyalofast® U.S. Pivotal Phase..
09/5/202315:05GLOBEAnika Reports First Quarter 2023 Financial Results

Su Consulta Reciente

Delayed Upgrade Clock